Clinical trial

Levels of Raltegravir in the Female Genital Tissue

NCT01327482

Study summary

ClinicalTrials.gov

Levels of Raltegravir in the Female Genital Tissue

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Raltegravir Normalized identity: raltegravir View linked drug · Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-10-01

PhaseNA

Conditions

HIVunresolved

Interventions

RaltegravirDRUG · verified · RxNorm: raltegravir

Sponsors & collaborators

University of Washingtonlead sponsor

Merck Sharp & Dohme LLCcollaborator

Mapped research locations

SeattleWashington, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01327482 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.